FDA-registered class II electromyographic diagnostic device that ages and evaluates muscle activity, distinguishes acute versus chronic injury, and objectively quantifies effort. Patented EFA-STM program provides employers and occupational-health teams an ADA/EEOC-compliant, securely stored baseline and post-injury comparison to establish pre-injury status and enable objective soft-tissue injury diagnosis and improved treatment outcomes for employees.